https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / Cancer 2007 Oct;110(7):1469-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / Cancer 2007 Oct;110(7):1469-772007-10-01 00:00:002019-02-15 08:38:10Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / Int J Immunopathol Pharmacol 2007 Oct-Dec;20(4):707-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / Int J Immunopathol Pharmacol 2007 Oct-Dec;20(4):707-172007-10-01 00:00:002019-02-15 09:16:53Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / J. Immunother. 2007 Oct;30(7):749-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / J. Immunother. 2007 Oct;30(7):749-612007-10-01 00:00:002019-02-15 09:16:55Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / Melanoma Res. 2007 Oct;17(5):316-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / Melanoma Res. 2007 Oct;17(5):316-222007-10-01 00:00:002019-02-15 09:19:38Dendritic cell immunotherapy for stage IV melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / Br. J. Nutr. 2007 Oct;98 Suppl 1:S29-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / Br. J. Nutr. 2007 Oct;98 Suppl 1:S29-352007-10-01 00:00:002007-10-01 00:00:00Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-25 / J Transl Med 2007 Sep;5:46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-25 / J Transl Med 2007 Sep;5:462007-09-25 00:00:002019-02-15 09:25:32Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-24 / Cancer Sci. 2007 Dec;98(12):1930-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-24 / Cancer Sci. 2007 Dec;98(12):1930-52007-09-24 00:00:002019-02-15 08:48:20Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc(Min/+) mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-19 / Int. J. Radiat. Oncol. Biol. Phys. 2008 Mar;70(4):1176-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-19 / Int. J. Radiat. Oncol. Biol. Phys. 2008 Mar;70(4):1176-822007-09-19 00:00:002019-02-15 08:35:20Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-15 / Cancer Res. 2007 Sep;67(18):8450-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-15 / Cancer Res. 2007 Sep;67(18):8450-52007-09-15 00:00:002019-02-15 09:25:34Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-10 / Clin. Immunol. 2007 Nov;125(2):184-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-10 / Clin. Immunol. 2007 Nov;125(2):184-932007-09-10 00:00:002019-02-15 09:19:37Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes
